Regulation 41 Amendment to Schedule 5I1

United Kingdom

(1)

Schedule 5 (procedural provisions relating to the refusal or amendment of, or imposition of conditions relating to, clinical trial authorisations and the suspension or termination of clinical trials) is amended as follows.

(2)

In paragraph 1^f1, for “regulation 26(1)” substitute “regulation 23(2)”.

(3)

In paragraph 2—

(a)

in sub-paragraph (1)—

(i)

in the opening words, for “an amendment to the clinical trial authorisation” substitute “a substantial modification”;

(ii)

in paragraph (a), for “amendment” substitute “modification”;

(iii)

in paragraph (b), for “amendment to the clinical trial authorisation” substitute “modification”;

(b)

in sub-paragraph (2), for “notice of amendment to a clinical trial authorisation” substitute “valid modification request”.

Regulation 41 Amendment to Schedule 5I1

Annotations

Commencement

Footnotes